Presented with Turner Pope Investments, this ValiRx Investor Webinar shows ValiRx CEO, Dr Suzanne Dilly as she speaks about ValiRx's progress and answers our shareholder's questions and queries.

In the webinar, Suzanne speaks about:

- Inaphaea BioLabs, which is currently being outfitted at Medicity, in Nottingham. Inaphaea will become a cell culture service laboratory to allow us to run our own cell culture experiments for clients, primarily focusing on women's health and oncology.

- Suzy also answers questions about Inaphaea, the lab progress, strategy and much more.

Watch the Investor Webinar in full below.